Funding for this research was provided by:
National Natural Science Foundation of China (81703720)
Key Research and Development Program of Shaanxi Province, (2017ZDXM-SF-008)
the Chinese Medicine Pharmaceutical Key Discipline of Shaanxi Province (303061107)
Key Research and Development Plan of Shaanxi Province (2018SF-314)
Subject Innovation Team of Shaanxi University of Chinese Medicine (2019-YL11)
Received: 1 December 2019
Accepted: 13 July 2020
First Online: 19 November 2020
Ethics approval and consent to participate
: The study was approved by the Ethical Committee of Shaanxi University of Chinese Medicine. All procedures performed in studies involving animals participants were in accordance with the ethical standards of the institutional and/or national research committee and with the the Basel Declaration outlines fundamental principles and the International Council for Laboratory Animal Science (ICLAS) .
: Not applicable.
: The authors declare no conflicts of interest.